HRT Financial’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,943
Closed -$493K 2362
2024
Q3
$493K Buy
+16,943
New +$493K ﹤0.01% 1468
2024
Q1
Sell
-44,292
Closed -$950K 2337
2023
Q4
$950K Buy
44,292
+32,087
+263% +$688K 0.01% 940
2023
Q3
$251K Buy
+12,205
New +$251K ﹤0.01% 1541
2022
Q4
Sell
-77,628
Closed -$2.38M 2404
2022
Q3
$2.38M Buy
77,628
+54,028
+229% +$1.66M 0.03% 523
2022
Q2
$694K Buy
+23,600
New +$694K 0.01% 1228